MCA

3.23%

15.0¢ murray cod australia limited

LV50,Yes good post. You should put it in the AS1 thread too.MCA,...

First 5 Last

4thekids

819 Posts.

01/02/19

08:58

Post #: 37293605

Originally posted by LV50: ↑
Interesting quarterly, going by their last quarterly they anticipated cash outflows for this quarter of $550,000 yet they came in at over $2.2 million. Quite concerning that the Company can not achieve anywhere near their forecast spending. Nearly 400% over forecast expenditure is a good reason for concern.

Another company i have been watching in the aquaculture space has been AS1 who looks to be going from strength to strength. Its interesting to see both MCA and AS1 grow side by side each quarter and puts into prospective how markets can value companies completely differently based purely on hype.

Dec 2018 Quarter AS1 MCA
1 Shares on issue (Fully diluted includes options and performance shares approx.) 143,000,000 497,000,000
2 Share price (31-1-19) $0.125 $0.16
3 Revenue $1,029,000 $627,000
4 Revenue increase +106% +10%
5 Loss for the quarter -$477,000 -$1,838,000
6 Market Cap $17,875,000 $79,520,000

MCA didn't really comment on what to expect next quarter or the rest of the year outlook yet AS1 management reconfirmed that the business is on track to reach cash-flow positive operations for the 2019 FY.

Why such the vast difference in valuations? Any ideas? I enjoy following both companies but trying to come to terms with how they are so vastly different in valuation.

I think both MCA and AS1 have a bright future and the aquaculture industry in Australia will only continue to gain more and more attention so i really hope MCA can make some ground towards being cash-flow positive as it will only be good for the whole industry.
Expand
LV50,

Yes good post. You should put it in the AS1 thread too.

MCA, I think will get there but will take time. MC actually higher than that as there is 530-million shares fully diluted.

Watching both keenly.

4TK

MCA Price at posting: 16.0¢ Sentiment: Hold Disclosure: Not Held

1 Upvote

0 Great analysis

Top Stories

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

CKA

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

BUX

Buxton projects new graphite province discovery at WA Narryer play

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

There are more pages in this discussion • 7 more messages in this thread...

First 5 Last

Add MCA (ASX) to my watchlist

(20min delay)
Last 15.0¢		Change -0.005(3.23%)		Mkt cap ! $158.6M

Open	High	Low	Value	Volume
15.0¢	15.0¢	14.5¢	$46.24K	313.2K

Buyers (Bids)

No.	Vol.	Price($)
3	418352	14.0¢

Sellers (Offers)

Price($)	Vol.	No.
15.5¢	213448	6

View Market Depth

No.	Vol.	Price($)
3	418352	0.140
1	207111	0.135
3	105923	0.130
2	108333	0.120
2	373913	0.115

Price($)	Vol.	No.
0.155	195448	5
0.160	177763	4
0.165	5050	1
0.180	20166	2
0.210	40000	1

Last trade - 15.05pm 04/10/2024 (20 minute delay)

MCA (ASX) Chart

LV50,Yes good post. You should put it in the AS1 thread too.MCA,...

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

BCI reaches close of funding facility for salt-first part of Mardie project

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Buxton projects new graphite province discovery at WA Narryer play

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

	Dec 2018 Quarter	AS1	MCA
1	Shares on issue (Fully diluted includes options and performance shares approx.)	143,000,000	497,000,000
2	Share price (31-1-19)	$0.125	$0.16
3	Revenue	$1,029,000	$627,000
4	Revenue increase	+106%	+10%
5	Loss for the quarter	-$477,000	-$1,838,000
6	Market Cap	$17,875,000	$79,520,000

LV50,Yes good post. You should put it in the AS1 thread too.MCA,...

Top Stories

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

BCI reaches close of funding facility for salt-first part of Mardie project

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Buxton projects new graphite province discovery at WA Narryer play

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News